Clinical Trial Update: Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 single-arm study evaluating pyrotinib maleate tablets with albumin-bound paclitaxel and trastuzumab as neoadjuvant therapy in HER2-positive early or loc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Pyrotinib maleate tablets (pyrotinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: West China Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN